Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1323182 | 0.97 | SHBG (0.32) | SHBGCYP1A2ADH1CADH1A | |
| SCHEMBL27352004 | 0.90 | SHBG (0.31) | SHBGCYP1A2ADH1CADH1A | |
| SCHEMBL28535642 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL3292769 | 0.86 | — | — | |
| SCHEMBL10501496 | 0.84 | — | — | |
| SCHEMBL7535948 | 0.78 | CYP1A2 (0.37) | SHBGCYP1A2ADH1CADH1A | |
| SCHEMBL301104 | 0.78 | CYP1A2 (0.37) | SHBGCYP1A2ADH1CADH1A | |
| SCHEMBL301180 | 0.77 | SHBG (0.36) | SHBGCYP1A2ADH1CADH1A | |
| Ammonia Solution, Strong SCHEMBL4079351 | 0.76 | CYP1A2 (0.36) | SHBGCYP1A2ADH1CADH1A | |
| SCHEMBL984692 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119894883-A | Methods and processes for preparing MCT4 inhibitors | 维托尔股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025050741-A1 | USE OF BIOMASS-BASED CS-PNIPAAM-MBAA@CU2+ CATALYST IN SYNTHESIS OF CHIRAL BORON COMPOUND | 湖北工程学院 | 2025-03-13 | — | — | WO | claimed |
| CN-118831653-A | Preparation method of noble metal catalyst based on chiral ferrocene biphosphine ligand and noble metal catalyst | 陕西瑞科新材料股份有限公司 | 2024-10-25 | — | — | CN | claimed |
| EP-4426727-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | claimed |
| CN-111417627-B | Hydrogenation of Imines Using RU Complexes | 弗门尼舍有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-118063383-A | Rhodium-catalyzed coupling method of cycloheptatriene and aromatic amine | 中国科学院大连化学物理研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-118026930-A | Isoquinoline derivative and synthesis method thereof | 湖南师范大学 | 2024-05-14 | — | — | CN | claimed |
| CN-113402375-B | Formation of alpha, beta-unsaturated carboxylic acids and salts thereof from metal lactones and anionic polyelectrolytes | 切弗朗菲利浦化学公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117624120-A | Preparation method of bripiprazole intermediate | 重庆圣华曦药业股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-114887666-B | Catalyst and application thereof | 山东师范大学 | 2023-12-22 | — | — | CN | claimed |
| WO-2007109365-A2 | PROCESS FOR THE SYNTHESIS OF ARYLAMINES FROM THE REACTION OF AN AROMATIC COMPOUND WITH AMMONIA OR A METAL AMIDE | YALE UNIVERSITY (US) | 2007-09-27 | — | — | WO | claimed |
| CN-1318362-C | One-step process for the preparation of 1, 3-diols | SHELL INT RESEARCH (NL) | 2007-05-30 | — | — | CN | claimed |
| US-7067654-B2 | Preparation of polyisocyanates containing uretdione groups | BAYER MATERIALSCIENCE AG (DE) | 2006-06-27 | — | — | US | claimed |
| CN-1635987-A | One step process for preparing a 1,3-diol | SHELL INT RESEARCH (NL) | 2005-07-06 | — | — | CN | claimed |
| CN-1511858-A | Low monomer content poly isocyanic ester containing urea diketone group | 拜尔公司 | 2004-07-14 | — | — | CN | claimed |
| US-20040110915-A1 | for production of polyurethanes via catalytic polymerization with trimethylphosphine; improved storage stability | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | US | claimed |
| CN-1502605-A | Prepartion of polyisocyanates containing uretdione groups | — | 2004-06-09 | — | — | CN | claimed |
| US-20040106789-A1 | Preparation of polyisocyanates containing uretdione groups | COVESTRO DEUTSCHLAND AG (DE) | 2004-06-03 | — | — | US | claimed |
| EP-1268060-A2 | ONE STEP PROCESS FOR PREPARING A 1,3-DIOL | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2003-01-02 | — | — | EP | claimed |
| WO-2001072675-A2 | ONE STEP PROCESS FOR PREPARING A 1,3-DIOL | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2001-10-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106789-A1 | Preparation of polyisocyanates containing uretdione groups | UROD, PUF60, UTS2R | SHBG 512/4885CYP1A2 905/4885ADH1C 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.